During the past decade, Seoul Red Cross Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Seoul Red Cross Hospital" are "COVID-19" (1 trials) and "Gastric Adenocarcinoma" (1 trials). Many other conditions were trialed in "Seoul Red Cross Hospital" in a lesser frequency.

Most popular intervention types in "Seoul Red Cross Hospital" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "D1+ distal subtotal gastrectomy" (1 trials), "D2 distal subtotal gastrectomy" (1 trials), "Placebo" (1 trials) and "Pyramax" (1 trials). Other intervention names were less common.

The vast majority of trials in "Seoul Red Cross Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Seoul Red Cross Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Seoul Red Cross Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Seoul Red Cross Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".